To cater to the growing demand of regulated markets, a new world class, cGMP commercial API manufacturing facility is being set up.  This state-of-the-art facility has independent manufacturing blocks being set up in a phased manner to cater to a wide range of APIs. This plant has been designed to comply with global quality requirements.

Sharon has also identified niche segment of Oncology for its future growth and envisaged setting up of state of the art facility for manufacturing of Oncology Products and offer for the same for marketing and distribution to companies worldwide.